MIRM | Mirum PharmaceuticalsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$87.03
+$1.29 (+1.50%)

Mirum Pharmaceuticals (MIRM) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2021.

The 50 SMA has sat below the 200 on the daily since Oct 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the weekly and the 4-hour, price sits between the 50 and the 200; on the daily it is below both.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $87.03 vs 50 $89.53 / 200 $98.52
Projection
No cross projected
Test
No active test
Last cross
Death cross 2 Oct 2026 ยท projected 26 bars out

Weekly as of 30 Oct 16:00 ET

Price
between the two $85.00 vs 50 $94.54 / 200 $52.04
Projection
No cross projected
Test
No active test
Last cross
No cross on record

4-hour as of 3 Nov 16:00 ET

Price
between the two $87.03 vs 50 $83.34 / 200 $99.98
Projection
No cross projected
Test
No active test
Last cross
Death cross 25 Aug 2026 ยท projected 27 bars out

Cross history

19
crosses on record since 2021
9 golden10 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
2 Oct 2026Death steepdaily26 bars outNot tested
25 Aug 2026Death4-hour27 bars outNot tested
29 Dec 2025Golden4-hour11 bars outNot tested
17 Dec 2025Death4-hour27 bars out1 bar cross test
18 Jun 2025Golden flatdaily16 bars outNot tested

About MIRM

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$56.9M
4-hour coverageYes, since Oct 2025
History on recordSince 2021
SectorHealthcare
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.